Montag A & Associates Inc Becton Dickinson & CO Transaction History

Montag A & Associates Inc

  • $2.09 Billion
  • Q3 2024

A detailed history of Montag A & Associates Inc transactions in Becton Dickinson & CO stock. As of the latest transaction made, Montag A & Associates Inc holds 5,701 shares of BDX stock, worth $1.27 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
5,701
Previous 5,069 12.47%
Holding current value
$1.27 Million
Previous $1.18 Million 16.05%
% of portfolio
0.07%
Previous 0.06%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
BUY
$221.47 - $242.41 $139,969 - $153,203
632 Added 12.47%
5,701 $1.37 Million
Q2 2024

Jul 31, 2024
BUY
$225.07 - $246.17 $3,376 - $3,692
15 Added 0.3%
5,069 $1.18 Million
Q1 2024

May 07, 2024
SELL
$233.45 - $247.73 $3,735 - $3,963
-16 Reduced 0.32%
5,054 $1.25 Million
Q4 2023

Feb 07, 2024
BUY
$232.24 - $267.23 $37,158 - $42,756
160 Added 3.26%
5,070 $1.24 Million
Q3 2023

Nov 09, 2023
SELL
$254.9 - $283.59 $608,701 - $677,212
-2,388 Reduced 32.72%
4,910 $1.27 Million
Q1 2023

May 11, 2023
SELL
$229.71 - $259.35 $918 - $1,037
-4 Reduced 0.05%
7,298 $1.81 Million
Q4 2022

Feb 02, 2023
SELL
$218.29 - $256.91 $73,127 - $86,064
-335 Reduced 4.39%
7,302 $1.86 Million
Q3 2022

Nov 09, 2022
SELL
$51.03 - $264.23 $8,930 - $46,240
-175 Reduced 2.24%
7,637 $1.7 Million
Q2 2022

Aug 10, 2022
SELL
$234.74 - $275.42 $181,688 - $213,175
-774 Reduced 9.01%
7,812 $1.93 Million
Q1 2022

May 02, 2022
SELL
$243.64 - $270.48 $864,922 - $960,204
-3,550 Reduced 29.25%
8,586 $2.28 Million
Q4 2021

Feb 09, 2022
SELL
$230.08 - $250.94 $240,203 - $261,981
-1,044 Reduced 7.92%
12,136 $2.98 Million
Q3 2021

Nov 08, 2021
SELL
$232.72 - $256.47 $114,498 - $126,183
-492 Reduced 3.6%
13,180 $3.24 Million
Q2 2021

Aug 03, 2021
SELL
$232.65 - $254.58 $58,395 - $63,899
-251 Reduced 1.8%
13,672 $3.33 Million
Q1 2021

May 14, 2021
SELL
$232.09 - $256.88 $90,050 - $99,669
-388 Reduced 2.71%
13,923 $3.39 Million
Q4 2020

Feb 12, 2021
SELL
$221.92 - $245.94 $77,450 - $85,833
-349 Reduced 2.38%
14,311 $3.58 Million
Q3 2020

Nov 12, 2020
SELL
$215.77 - $276.76 $181,462 - $232,755
-841 Reduced 5.43%
14,660 $3.41 Million
Q2 2020

Aug 04, 2020
SELL
$219.9 - $263.41 $84,001 - $100,622
-382 Reduced 2.41%
15,501 $3.71 Million
Q1 2020

May 06, 2020
BUY
$195.69 - $279.01 $473,569 - $675,204
2,420 Added 17.98%
15,883 $3.65 Million
Q4 2019

Feb 05, 2020
BUY
$236.45 - $266.82 $126,027 - $142,215
533 Added 4.12%
13,463 $3.66 Million
Q3 2019

Nov 04, 2019
BUY
$230.58 - $256.08 $17,062 - $18,949
74 Added 0.58%
12,930 $3.27 Million
Q2 2019

Aug 06, 2019
BUY
$217.4 - $246.08 $74,133 - $83,913
341 Added 2.72%
12,856 $3.24 Million
Q1 2019

May 01, 2019
BUY
$206.05 - $248.17 $688,413 - $829,135
3,341 Added 36.42%
12,515 $3.13 Million
Q4 2018

Feb 06, 2019
BUY
$204.73 - $257.93 $183,847 - $231,621
898 Added 10.85%
9,174 $2.07 Million
Q3 2018

Nov 07, 2018
SELL
$233.07 - $256.0 $1,631 - $1,792
-7 Reduced 0.08%
8,276 $2.16 Million
Q2 2018

Aug 08, 2018
SELL
$208.1 - $233.85 $24,347 - $27,360
-117 Reduced 1.39%
8,283 $1.98 Million
Q2 2018

Aug 01, 2018
BUY
$208.1 - $233.85 $34,752 - $39,052
167 Added 2.03%
8,400 $2.01 Million
Q1 2018

May 07, 2018
BUY
$205.46 - $240.27 $51,159 - $59,827
249 Added 3.12%
8,233 $1.78 Million
Q4 2017

Feb 09, 2018
BUY
$189.0 - $222.64 $221,508 - $260,934
1,172 Added 17.2%
7,984 $1.71 Million
Q3 2017

Nov 06, 2017
BUY
$186.89 - $198.9 $1.27 Million - $1.35 Million
6,812
6,812 $1.34 Million

Others Institutions Holding BDX

# of Institutions
1,737
Shares Held
250M
Call Options Held
690K
Put Options Held
787K
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.3B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Montag A & Associates Inc Portfolio

Follow Montag A & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Montag A & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Montag A & Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email